These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 28109443

  • 1. Separation of Two Distinct O-Glycoforms of Human IgA1 by Serial Lectin Chromatography Followed by Mass Spectrometry O-Glycan Analysis.
    Lehoux S, Ju T.
    Methods Enzymol; 2017; 585():61-75. PubMed ID: 28109443
    [Abstract] [Full Text] [Related]

  • 2. Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
    Lehoux S, Mi R, Aryal RP, Wang Y, Schjoldager KT, Clausen H, van Die I, Han Y, Chapman AB, Cummings RD, Ju T.
    Mol Cell Proteomics; 2014 Nov; 13(11):3097-113. PubMed ID: 25071157
    [Abstract] [Full Text] [Related]

  • 3. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
    Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.
    J Proteomics; 2013 Oct 30; 92():299-312. PubMed ID: 23891555
    [Abstract] [Full Text] [Related]

  • 4. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Oct 30; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 5. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
    Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J.
    J Am Soc Nephrol; 1999 Aug 30; 10(8):1763-71. PubMed ID: 10446944
    [Abstract] [Full Text] [Related]

  • 6. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
    Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J.
    PLoS One; 2014 Aug 30; 9(2):e99026. PubMed ID: 24918438
    [Abstract] [Full Text] [Related]

  • 7. O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.
    Yu G, Zhang Y, Meng B, Xie X, Wang Z, Ying W, Lv J, Zhang H.
    Nephrol Dial Transplant; 2021 Dec 31; 37(1):33-41. PubMed ID: 34152412
    [Abstract] [Full Text] [Related]

  • 8. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
    Ohyama Y, Yamaguchi H, Nakajima K, Mizuno T, Fukamachi Y, Yokoi Y, Tsuboi N, Inaguma D, Hasegawa M, Renfrow MB, Novak J, Yuzawa Y, Takahashi K.
    Sci Rep; 2020 Jan 20; 10(1):671. PubMed ID: 31959827
    [Abstract] [Full Text] [Related]

  • 9. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar 20; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 10. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 20; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 11. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
    Takahashi K, Wall SB, Suzuki H, Smith AD, Hall S, Poulsen K, Kilian M, Mobley JA, Julian BA, Mestecky J, Novak J, Renfrow MB.
    Mol Cell Proteomics; 2010 Nov 20; 9(11):2545-57. PubMed ID: 20823119
    [Abstract] [Full Text] [Related]

  • 12. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 13. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC.
    J Nephrol; 1999 Jul 13; 12(2):76-84. PubMed ID: 10378662
    [Abstract] [Full Text] [Related]

  • 14. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.
    J Biol Chem; 2005 May 13; 280(19):19136-45. PubMed ID: 15728186
    [Abstract] [Full Text] [Related]

  • 15. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.
    Am J Kidney Dis; 2003 Sep 13; 42(3):486-96. PubMed ID: 12955676
    [Abstract] [Full Text] [Related]

  • 16. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec 13; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 17. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y.
    J Nephrol; 2010 Jan 22; 23(1):70-6. PubMed ID: 20091489
    [Abstract] [Full Text] [Related]

  • 19. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC, Poon PY, Lai KN.
    J Lab Clin Med; 1999 Feb 22; 133(2):152-60. PubMed ID: 9989767
    [Abstract] [Full Text] [Related]

  • 20. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
    Hiki Y, Horie A, Yasuda Y, Iwase H, Sugiyama S.
    Acta Otolaryngol Suppl; 2004 Dec 22; (555):28-31. PubMed ID: 15768794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.